Application 216537
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | TABLET;ORAL | 10MG;100MG | No | No |
| 002 | CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | TABLET;ORAL | 25MG;100MG | No | No |
| 003 | CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | TABLET;ORAL | 25MG;250MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 59651-456 | Carbidopa and Levodopa | Carbidopa and Levodopa | Aurobindo Pharma Limited | ANDA | Current |
| 59651-456 | Carbidopa and Levodopa | Carbidopa and Levodopa | Aurobindo Pharma Limited | ANDA | Current |
| 59651-457 | Carbidopa and Levodopa | Carbidopa and Levodopa | Aurobindo Pharma Limited | ANDA | Current |
| 59651-457 | Carbidopa and Levodopa | Carbidopa and Levodopa | Aurobindo Pharma Limited | ANDA | Current |
| 59651-458 | Carbidopa and Levodopa | Carbidopa and Levodopa | Aurobindo Pharma Limited | ANDA | Current |
| 59651-458 | Carbidopa and Levodopa | Carbidopa and Levodopa | Aurobindo Pharma Limited | ANDA | Current |